Strategic Blueprint’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Strategic Blueprint’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,404	Closed	-$252K	–	684
2025 Q3	$252K	Buy	+1,404	New	+$239K	0.01%	645
2025 Q2	–	Sell	-1,643	Closed	-$280K	–	695
2025 Q1	$280K	Buy	1,643 +75	+5%	+$13K	0.02%	556
2024 Q4	$261K	Sell	1,568 -26	-2%	-$4.44K	0.02%	561
2024 Q3	$274K	Sell	1,594 -86	-5%	-$14.2K	0.02%	534
2024 Q2	$259K	Sell	1,680 -53	-3%	-$7.95K	0.02%	524
2024 Q1	$266K	Sell	1,733 -17	-1%	-$2.59K	0.02%	517
2023 Q4	$277K	Buy	1,750 +50	+3%	+$7.18K	0.02%	479
2023 Q3	$249K	Sell	1,700 -60	-3%	-$9.14K	0.02%	463
2023 Q2	$270K	Buy	1,760 +26	+1%	+$4.05K	0.03%	447
2023 Q1	$269K	Buy	+1,734	New	+$272K	0.03%	440
2021 Q3	–	Sell	-951	Closed	-$164K	–	677
2021 Q2	$164K	Buy	+951	New	+$157K	0.03%	402

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

360 Financial Wayzata, Minnesota $332M AUM 20.7% 1-Year Est. Return

Strategic Blueprint's FBT Position: Q4 2025 in Review

Strategic Blueprint sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2025, closing a stake of 1,404 shares — an estimated $252K sold.

Strategic Blueprint first reported a position in FBT in Q2 2021 and held it in 11 quarters. The position peaked at $280K in Q1 2025. 279 funds tracked by Wall St. Rank hold FBT as of Q4 2025.

Strategic Blueprint reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2025 after selling out during the quarter.
Strategic Blueprint sold 1,404 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2025, an estimated $252K.
Strategic Blueprint first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2021 and held it in 11 quarters.
Strategic Blueprint's First Trust NYSE Arca Biotechnology Index Fund position peaked at $280K in Q1 2025.
279 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2025.

Based on Strategic Blueprint's 13F filing for Q4 2025, filed 30 Jan 2026.